Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/22 16:05 | 9/14/22 | TARA | Health | BioPrd | Biological Products, (No Diag | Opaleye Management Inc. | MA | T | P.m | 94 | 3.93 | 0 | 24 | 1 | 2,708 | I | |||||||||||||||
8/15/22 17:49 | 8/11/22 | TARA | Health | BioPrd | Biological Products, (No Diag | Shefferman Jesse | NY | DO | CEO,P | P | 35 | 3.84 | 0 | 9 | 1 | 879 | D | ||||||||||||||
7/5/22 17:00 | 6/30/22 | TARA | Health | BioPrd | Biological Products, (No Diag | Beshar Luke M | NY | D | P | 31 | 3.10 | 0 | 10 | 5 | 198 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |